Zeineddine M - Search Results

1

Effectiveness of alternative dose fingolimod for multiple sclerosis.

Longbrake EE, Kantor D, Pawate S, Bradshaw MJ, von Geldern G, Chahin S, Cross AH, Parks BJ, Rice M, Khoury SJ, Yamout B, Zeineddine M, Russell-Giller S, Caminero-Rodriguez A, Edwards K, Lathi E, VanderKodde D, Meador W, Berkovich R, Ge L, Bacon TE, Kister I. Longbrake EE, et al. Among authors: zeineddine m. Neurol Clin Pract. 2018 Apr;8(2):102-107. doi: 10.1212/CPJ.0000000000000434. Neurol Clin Pract. 2018. PMID: 29708225 Free PMC article.

2

Safety and efficacy of reduced fingolimod dosage treatment.

Yamout BI, Zeineddine MM, Sawaya RA, Khoury SJ. Yamout BI, et al. Among authors: zeineddine mm. J Neuroimmunol. 2015 Aug 15;285:13-5. doi: 10.1016/j.jneuroim.2015.05.012. Epub 2015 May 15. J Neuroimmunol. 2015. PMID: 26198913

3

Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.

Yamout BI, Zeineddine MM, Tamim H, Khoury SJ. Yamout BI, et al. Among authors: zeineddine mm. J Neuroimmunol. 2015 Dec 15;289:93-7. doi: 10.1016/j.jneuroim.2015.10.015. Epub 2015 Oct 26. J Neuroimmunol. 2015. PMID: 26616877

4

JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern study.

Alroughani R, Akhtar S, Ahmed SF, Khoury SJ, Al-Hashel JY, Sahraian MA, Al Jumah M, Zeineddine M, Farhat S, Doumiati H, Yamout BI. Alroughani R, et al. Among authors: zeineddine m. J Neurol Sci. 2016 Jan 15;360:61-5. doi: 10.1016/j.jns.2015.11.044. Epub 2015 Nov 24. J Neurol Sci. 2016. PMID: 26723975

5

Three cases of herpes zoster radiculitis in MS patients treated with natalizumab.

Yamout BI, Abou Zeid N, Taha AJ, Zeineddine MM, Khoury SJ. Yamout BI, et al. Among authors: zeineddine mm. Mult Scler Relat Disord. 2016 Sep;9:122-4. doi: 10.1016/j.msard.2016.07.012. Epub 2016 Jul 25. Mult Scler Relat Disord. 2016. PMID: 27645358

6

Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder.

Yamout BI, Beaini S, Zeineddine MM, Akkawi N. Yamout BI, et al. Among authors: zeineddine mm. Mult Scler. 2017 Aug;23(9):1297-1300. doi: 10.1177/1352458517694086. Epub 2017 Apr 10. Mult Scler. 2017. PMID: 28391740

7

Letter to the editor.

Yamout BI, Zeineddine MM. Yamout BI, et al. Among authors: zeineddine mm. Mult Scler. 2018 Mar;24(3):363. doi: 10.1177/1352458517717091. Epub 2017 Jul 27. Mult Scler. 2018. PMID: 28747148 No abstract available.

8

Rebound syndrome after teriflunomide cessation in a patient with multiple sclerosis.

Yamout BI, Said M, Hannoun S, Zeineddine M, Massouh J, Khoury SJ. Yamout BI, et al. Among authors: zeineddine m. J Neurol Sci. 2017 Sep 15;380:79-81. doi: 10.1016/j.jns.2017.07.014. Epub 2017 Jul 9. J Neurol Sci. 2017. PMID: 28870594

9

Efficacy and safety of natalizumab extended interval dosing.

Yamout BI, Sahraian MA, Ayoubi NE, Tamim H, Nicolas J, Khoury SJ, Zeineddine MM. Yamout BI, et al. Among authors: zeineddine mm. Mult Scler Relat Disord. 2018 Aug;24:113-116. doi: 10.1016/j.msard.2018.06.015. Epub 2018 Jul 5. Mult Scler Relat Disord. 2018. PMID: 29982107

10

Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study.

Yamout BI, El-Ayoubi NK, Nicolas J, El Kouzi Y, Khoury SJ, Zeineddine MM. Yamout BI, et al. Among authors: zeineddine mm. J Immunol Res. 2018 Nov 12;2018:9084759. doi: 10.1155/2018/9084759. eCollection 2018. J Immunol Res. 2018. PMID: 30539030 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page